THEODORE HANDRUP: Open Payments
NPI 1073594974 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 47 payments from 12 companies in 2025. Trend: 2023 $1,113 · 2024 $1,325 · 2025 $1,153
Food & beverage: $1,042Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $335 |
| Teva Pharmaceuticals USA, Inc. | 5 | $214 |
| ABBVIE INC. | 5 | $115 |
| Alkermes, Inc. | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $72 |
| Corium, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: COBENFY, REXULTI, VRAYLAR, LYBALVI, AUSTEDO XR, SPRAVATO, Azstarys, Auvelity.
Industry payments across IL — which companies pay providers there.
